Intrust Bank Na Neurocrine Biosciences Inc Transaction History
Intrust Bank Na
- $978 Million
- Q4 2024
A detailed history of Intrust Bank Na transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Intrust Bank Na holds 2,734 shares of NBIX stock, worth $325,646. This represents 0.04% of its overall portfolio holdings.
Number of Shares
2,734
Previous 2,826
3.26%
Holding current value
$325,646
Previous $325,000
14.77%
% of portfolio
0.04%
Previous 0.03%
Shares
16 transactions
Others Institutions Holding NBIX
# of Institutions
654Shares Held
96.5MCall Options Held
282KPut Options Held
281K-
Black Rock Inc. New York, NY14.2MShares$1.69 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$1.21 Billion0.02% of portfolio
-
State Street Corp Boston, MA4.89MShares$583 Million0.03% of portfolio
-
Dodge & Cox San Francisco, CA3.02MShares$359 Million0.26% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.54MShares$302 Million0.06% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $11.4B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...